<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-10T16:44:39+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NGA-H-NASCP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Reach, Expand and Sustain Project (REACH) - Nigeria (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Nigeria, HIV, National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To end HIV epidemics by the year 2030; End vertical transmission of HIV. Objectives: To achieve 95-95-95 target by 2025; Scale-up PMTCT services (includign reaching womne who cannot access services from health facilities).</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="15" role="2" crs-channel-code="12004">
      <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
    </participating-org>
    <participating-org type="15" role="4" crs-channel-code="12004">
      <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
    </participating-org>
    <other-identifier ref="NGA-H-NASCPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Jean-Thomas Nouboussi</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>jean.nouboussi@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NG" percentage="100">
      <narrative>Nigeria</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="68.35">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="31.65">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="9.87">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="12.65">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="1.66">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="e71b58f8-6d5d-4f73-93c5-cea93aefb0c3" percentage="4.32">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="a4e4d0e7-9dfd-49d8-8030-0f9cc9b713fc" percentage="1.76">
        <description>
          <narrative>HIV -&gt; Prevention program stewardship -&gt; Prevention program stewardship</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.71">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="28c1900d-472f-4af5-94d7-2b92f93ab743" percentage="0.84">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Increasing access to justice (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="e0bd4666-bd16-440a-81d4-ded76d1d1b10" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="23.5">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="423a40f4-4716-48a1-9c6c-7b78ede223af" percentage="2.18">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="f4ee9261-d065-449a-8c27-d7a734d6ccae" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Drug resistance</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="10.17">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="1.92">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="20.75">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="f9c0078b-d557-4047-b352-b4b2eba7e5b8" percentage="0.28">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory Information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="19ae85a9-12db-4fb8-9313-84f9feef29a0" percentage="0.54">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="0.33">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="0.36">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.38">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="38ed2119-0193-4f73-9333-90fbd5a8cc0b" percentage="2.6">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="2.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="2.35">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="85fbea77-53b5-4647-bd23-d3053191c7bb" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveillance for HIV, tuberculosis and malaria</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">2739637.88</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">12223933.17</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">8997918.48</value>
    </budget>
    <capital-spend percentage="1.65" />
    <transaction ref="8d9a88c2-c359-45ee-934c-8e824a84460b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-02" />
      <value currency="USD" value-date="2024-02-02">12822293.09</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7e474b34-cb9e-48a4-b318-ceb8fa0ef177">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-12" />
      <value currency="USD" value-date="2024-02-12">12938287.00</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bf90567e-b078-485c-a8c2-efa5fec49281">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-12" />
      <value currency="USD" value-date="2024-02-12">-12822293.09</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5728170-023c-46b5-bf76-206a16b8244a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-15" />
      <value currency="USD" value-date="2024-03-15">6.15</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0879bf0f-d4e6-4b4c-8ef1-81e60d42f074">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-26" />
      <value currency="USD" value-date="2024-03-26">1485035.71</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="22fd4ce1-75d8-4b37-8017-38d295c6ea8d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-13" />
      <value currency="USD" value-date="2024-08-13">1000000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="34a5d9fb-84ca-4984-a160-15726280269d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-12" />
      <value currency="USD" value-date="2024-12-12">422770.24</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="888b1720-279d-480a-b9d1-d4e0762d2740">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-09" />
      <value currency="USD" value-date="2025-01-09">804574.02</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bb67b62b-74e8-4d8d-8283-0eff605ee7e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-18" />
      <value currency="USD" value-date="2025-03-18">2000692.46</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d81bdf58-48f1-41f5-8903-85ed08e231fe">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">299029.19</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8d991002-b766-4fef-9b49-77eff05392a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">296857.80</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d4fd656d-b35d-46d3-84a5-4359ae6718ec">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">12071.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fbe2ba97-6102-4626-8b1d-ec95ddc38912">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-24" />
      <value currency="USD" value-date="2025-07-24">-6617250.43</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3351abd-7e04-46bf-9297-7074df7787a9">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-24" />
      <value currency="USD" value-date="2025-07-24">8187245.08</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="46e0c076-1ec9-45c9-9428-dfe451ace020">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">231150.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4b1e99dd-1b55-4b10-ac49-b2e04915af10">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">10.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a65ae2f8-293d-4df1-be43-c39561e202cf">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">500000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="74e99cd1-beef-464c-9316-0fda05bb4161">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">6386532.29</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="499c77de-c37b-4fcb-a332-9e46fe03859e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">691623.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="700ab640-30da-4320-9d94-7c56fe0a9b82">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-09" />
      <value currency="USD" value-date="2025-12-09">12071.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c2afc6dd-f3a9-47bb-83ad-2364126dc9b9">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-02" />
      <value currency="USD" value-date="2026-02-02">117374.40</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0efd25c-8a71-464e-9546-81a5785a38d3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-14" />
      <value currency="USD" value-date="2026-03-14">2128811.76</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fa37925e-bbdf-4094-bbce-5c0b2fd1be41">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-14" />
      <value currency="USD" value-date="2026-03-14">-365858.79</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3d5ee61-0ee7-4b00-bd22-0aa803c33ad7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">500000.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf431158-27e6-44bd-b0fc-07f6ae4c6f37">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-20" />
      <value currency="USD" value-date="2026-03-20">193037.15</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8dfe7ecc-c838-41c4-be2b-7c54af7513fa">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-08" />
      <value currency="USD" value-date="2026-04-08">117374.40</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8c797bbe-c3d4-4260-a65c-bfaecd771634">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-18" />
      <value currency="USD" value-date="2026-04-18">-193037.15</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8c3a7ac-fc7c-4b56-94ef-679311a01040">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-18" />
      <value currency="USD" value-date="2026-04-18">273381.20</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aea6415c-771b-4509-95bb-2f794c005ddf">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-07" />
      <value currency="USD" value-date="2026-05-07">368997.40</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e025933-4fdc-4fbf-b904-60abda872973">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-09" />
      <value currency="USD" value-date="2026-07-09">-1628811.76</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d177a57a-ddbe-4f96-9dc7-5541d306ff8a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-09" />
      <value currency="USD" value-date="2026-07-09">7185283.62</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="09bd4be1-db7e-41c3-829d-6b0295636647">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-09" />
      <value currency="USD" value-date="2026-07-09">-368997.40</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5cdc2ef6-2139-44c3-ba71-868ca1983abf">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">2725912.61</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bde0168a-f4f1-4a95-94bb-d981c018b304">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">742487.70</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="083e3360-cb8a-4a66-b9e9-fbb7b4055d1b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-22" />
      <value currency="USD" value-date="2026-09-22">274348.00</value>
      <description>
        <narrative>Global Fund disbursement to NGA-H-NASCPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c6a9f0fe-d6b2-4071-a69c-dba613846ba6">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-08" />
      <value currency="USD" value-date="2026-10-08">866.35</value>
      <description>
        <narrative>Funds returned to the Global Fund from NGA-H-NASCPP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3b37314e-8a34-4166-a12e-0b36ac0c16ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-15" />
      <value currency="USD" value-date="2026-10-15">-866.35</value>
      <description>
        <narrative>Global Fund commitment to NGA-H-NASCPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="NGA-H-NASCPP01-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">1739637.89</value>
      <description>
        <narrative>Expenditure reported by National AIDS, Viral Hepatitis and STIs Control Programme for NGA-H-NASCPP01, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="NGA-H-NASCPP01-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">7824691.00</value>
      <description>
        <narrative>Expenditure reported by National AIDS, Viral Hepatitis and STIs Control Programme for NGA-H-NASCPP01, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="15">
        <narrative>National AIDS, Viral Hepatitis and STIs Control Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NGA-H-NASCP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NGA/2023/TB_HIV/en/NGA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - TB/HIV - Nigeria - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1535-NGA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 11390; Denominator: 96517; Percentage: 11.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 11052; Denominator: 26145; Percentage: 42.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 11052; Denominator: 26145; Percentage: 42.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 338; Denominator: 26145; Percentage: 1.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 338; Denominator: 26145; Percentage: 1.29%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 17414; Denominator: 87070; Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 34828; Denominator: 87070; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17528; Denominator: 87070; Percentage: 20.13%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17414; Denominator: 87070; Percentage: 20%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6992; Denominator: 87070; Percentage: 8.03%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 23248.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 313.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 28451.85; Denominator: 81291; Percentage: 35%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 56903.8; Denominator: 81291; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26449; Denominator: 81291; Percentage: 32.54%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 28451.85; Denominator: 81291; Percentage: 35%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14604; Denominator: 81291; Percentage: 17.97%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 21865.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 309.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 35982.2; Denominator: 75752; Percentage: 47.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 35982.2; Denominator: 75752; Percentage: 47.5%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2068967; Denominator: 7985986; Percentage: 25.91%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 2061691; Denominator: 7707635; Percentage: 26.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 2061691; Denominator: 7707635; Percentage: 26.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 7276; Denominator: 7707635; Percentage: 0.09%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 7276; Denominator: 7707635; Percentage: 0.09%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1976156; Denominator: 8697518; Percentage: 22.72%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3952312; Denominator: 8697518; Percentage: 45.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5202964; Denominator: 8697518; Percentage: 59.82%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1976156; Denominator: 8697518; Percentage: 22.72%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3553697; Denominator: 8697518; Percentage: 40.86%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 5174909.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 28244.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3336042.38; Denominator: 8896113; Percentage: 37.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6672084.8; Denominator: 8896113; Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6393292; Denominator: 8896113; Percentage: 71.87%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3336042.38; Denominator: 8896113; Percentage: 37.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3209861; Denominator: 8896113; Percentage: 36.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 6384892.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 8400.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4322843.9; Denominator: 9100724; Percentage: 47.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4322843.9; Denominator: 9100724; Percentage: 47.5%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 242339; Denominator: 1911502; Percentage: 12.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1708370; Denominator: 1860826; Percentage: 91.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1708370; Denominator: 1860826; Percentage: 91.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3RH" />
          <comment>
            <narrative>Numerator: 44218; Denominator: 44218; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="3RH" />
          <comment>
            <narrative>Numerator: 44218; Denominator: 44218; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 1385; Denominator: 3932; Percentage: 35.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 1385; Denominator: 3932; Percentage: 35.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 638278; Denominator: 689371; Percentage: 92.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="6H" />
          <comment>
            <narrative>Numerator: 638278; Denominator: 689371; Percentage: 92.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1131747; Denominator: 1222131; Percentage: 92.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1131747; Denominator: 1222131; Percentage: 92.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="RIF" />
          <comment>
            <narrative>Numerator: 6458; Denominator: 6458; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="TPT regimen" value="RIF" />
          <comment>
            <narrative>Numerator: 6458; Denominator: 6458; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 15%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 145242; Denominator: 1629359; Percentage: 8.91%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 101464; Denominator: 1629359; Percentage: 6.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 141926.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3RH" />
            <comment>
              <narrative>Numerator: 118.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 2803.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 35298.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 21200.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="RIF" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 17%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 17%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 215759; Denominator: 1738406; Percentage: 12.41%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 17%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 181024; Denominator: 1738406; Percentage: 10.41%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 211166.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="3RH" />
            <comment>
              <narrative>Numerator: 120.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 2993.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="6H" />
            <comment>
              <narrative>Numerator: 137173.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 87556.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TPT regimen" value="RIF" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="81.3">
          <comment>
            <narrative>Numerator: 1554089.33; Denominator: 1911502.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 131896; Denominator: 131896.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="120.39">
            <comment>
              <narrative>Numerator: 99858; Denominator: 82943.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="92.17">
            <comment>
              <narrative>Numerator: 108214; Denominator: 117409.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="88.52">
            <comment>
              <narrative>Numerator: 55477; Denominator: 62672.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="31.69">
          <comment>
            <narrative>Numerator: 50676; Denominator: 159923.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="50.28">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25480; Denominator: 50676.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="50.28">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25480; Denominator: 50676.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="49.72">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 25196; Denominator: 50676.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="49.72">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 25196; Denominator: 50676.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="48.71">
            <comment>
              <narrative>Numerator: 64255; Denominator: 131922.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="59">
            <comment>
              <narrative>Numerator: 77834; Denominator: 131922.</narrative>
            </comment>
          </target>
          <actual value="37.76">
            <comment>
              <narrative>Numerator: 49820; Denominator: 131922.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="59">
            <comment>
              <narrative>Numerator: 77834; Denominator: 131922.</narrative>
            </comment>
          </target>
          <actual value="37.76">
            <comment>
              <narrative>Numerator: 49820; Denominator: 131922.</narrative>
            </comment>
          </actual>
          <actual value="50.21">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 25016; Denominator: 49820.</narrative>
            </comment>
          </actual>
          <actual value="49.79">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 24804; Denominator: 49820.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="69.63">
            <comment>
              <narrative>Numerator: 84335; Denominator: 121114.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 90836; Denominator: 121114.</narrative>
            </comment>
          </target>
          <actual value="38.41">
            <comment>
              <narrative>Numerator: 46519; Denominator: 121114.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 90836; Denominator: 121114.</narrative>
            </comment>
          </target>
          <actual value="38.41">
            <comment>
              <narrative>Numerator: 46519; Denominator: 121114.</narrative>
            </comment>
          </actual>
          <actual value="49.8">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 23166; Denominator: 46519.</narrative>
            </comment>
          </actual>
          <actual value="50.2">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 23353; Denominator: 46519.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="88.55">
            <comment>
              <narrative>Numerator: 97967; Denominator: 110629.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 105098; Denominator: 110629.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="89.27">
          <comment>
            <narrative>Numerator: 1706470; Denominator: 1911502.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 658206; Denominator: 658206.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 658206; Denominator: 658206.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1166041; Denominator: 1166041.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1166041; Denominator: 1166041.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1845603; Denominator: 1942740.</narrative>
            </comment>
          </target>
          <actual value="65.06">
            <comment>
              <narrative>Numerator: 1060122; Denominator: 1629356.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1845603; Denominator: 1942740.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1845603; Denominator: 1942740.</narrative>
            </comment>
          </target>
          <actual value="65.06">
            <comment>
              <narrative>Numerator: 1060122; Denominator: 1629356.</narrative>
            </comment>
          </actual>
          <actual value="96.88">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1027006; Denominator: 1060122.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 33; Denominator: 1060122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1824237; Denominator: 1920249.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1824237; Denominator: 1920249.</narrative>
            </comment>
          </target>
          <actual value="67.41">
            <comment>
              <narrative>Numerator: 1294518; Denominator: 1920249.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1824237; Denominator: 1920249.</narrative>
            </comment>
          </target>
          <actual value="67.41">
            <comment>
              <narrative>Numerator: 1294518; Denominator: 1920249.</narrative>
            </comment>
          </actual>
          <actual value="96.87">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1254036; Denominator: 1294518.</narrative>
            </comment>
          </actual>
          <actual value="3.13">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 40482; Denominator: 1294518.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1803108; Denominator: 1898008.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1803108; Denominator: 1898008.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="96.34">
          <comment>
            <narrative>Numerator: 1911502; Denominator: 1984170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="98.19">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1222131; Denominator: 1244707.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="98.19">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1222131; Denominator: 1244707.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="93.23">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 689371; Denominator: 739463.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="93.23">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 689371; Denominator: 739463.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1942740; Denominator: 1942740.</narrative>
            </comment>
          </target>
          <actual value="83.87">
            <comment>
              <narrative>Numerator: 1629356; Denominator: 1942740.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1942740; Denominator: 1942740.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1942740; Denominator: 1942740.</narrative>
            </comment>
          </target>
          <actual value="83.87">
            <comment>
              <narrative>Numerator: 1629356; Denominator: 1942740.</narrative>
            </comment>
          </actual>
          <actual value="65.09">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1060629; Denominator: 1629359.</narrative>
            </comment>
          </actual>
          <actual value="34.91">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 568730; Denominator: 1629359.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1920249; Denominator: 1920249.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1920249; Denominator: 1920249.</narrative>
            </comment>
          </target>
          <actual value="90.53">
            <comment>
              <narrative>Numerator: 1738406; Denominator: 1920249.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1920249; Denominator: 1920249.</narrative>
            </comment>
          </target>
          <actual value="90.53">
            <comment>
              <narrative>Numerator: 1738406; Denominator: 1920249.</narrative>
            </comment>
          </actual>
          <actual value="65.4">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1136949; Denominator: 1738406.</narrative>
            </comment>
          </actual>
          <actual value="34.48">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 599324; Denominator: 1738406.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1898008; Denominator: 1898008.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1898008; Denominator: 1898008.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="33.55">
          <comment>
            <narrative>Numerator: 32381; Denominator: 96517.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="27.5">
            <comment>
              <narrative>Numerator: 23944.5; Denominator: 87070.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 47889; Denominator: 87070.</narrative>
            </comment>
          </target>
          <actual value="30.4">
            <comment>
              <narrative>Numerator: 26466; Denominator: 87070.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="27.5">
            <comment>
              <narrative>Numerator: 23944.5; Denominator: 87070.</narrative>
            </comment>
          </target>
          <actual value="17.32">
            <comment>
              <narrative>Numerator: 15081; Denominator: 87070.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 60968; Denominator: 81291.</narrative>
            </comment>
          </target>
          <actual value="34.11">
            <comment>
              <narrative>Numerator: 27728; Denominator: 81291.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="37.5">
            <comment>
              <narrative>Numerator: 30484; Denominator: 81291.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="37.5">
            <comment>
              <narrative>Numerator: 30484; Denominator: 81291.</narrative>
            </comment>
          </target>
          <actual value="16.39">
            <comment>
              <narrative>Numerator: 13320; Denominator: 81291.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="47.5">
            <comment>
              <narrative>Numerator: 35982; Denominator: 75752.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="47.5">
            <comment>
              <narrative>Numerator: 35982; Denominator: 75752.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>